Microvision 8-K Filings

MicroVision, Inc. completed a registered public offering of 6,800,000 shares of common stock together with warrants to purchase 6,800,000 shares. The securities were sold as units at a combined offering price of $2.50 per share and accompanying warrant, generating gross proceeds of $17.0 million and net proceeds of approximately $15.6 million after fees and expenses, excluding any future warrant exercises.

The warrants are immediately exercisable at $2.50 per share and remain exercisable for five years from closing. WestPark Capital, Inc. acted as sole placement agent on a reasonable best efforts basis, receiving a 6.5% cash commission and $115,000 in expense reimbursement. MicroVision plans to use the net proceeds for general corporate purposes, including working capital and capital expenditures.

For 45 days after closing, the company agreed not to issue additional common equity or price-reset securities (with limited exceptions), and not to make additional repayments on its senior secured convertible notes maturing March 1, 2028.

MicroVision, Inc. appointed Christine Chambers as Chief Financial Officer and principal financial and accounting officer, effective August 27, 2026. She brings more than two decades of financial leadership across public and high-growth technology companies, including prior CFO roles at Fusemachines, PetMed Express, and RealNetworks.

Her compensation package includes an annual base salary of $425,000, a target annual bonus of 65% of base salary, a one-time new-hire RSU award valued at $1,000,000 vesting over four years, and an annual long-term RSU opportunity valued at $800,000 vesting over three years, all subject to continued employment and equity plan terms. Three months after her start date, she will participate in MicroVision’s Key Executive Severance and Change in Control Plan as a Tier 2 Executive. Interim CFO Stephen Hrynewich will step down from the interim role on the Effective Date but remain in a senior finance role; his transition is stated not to result from any disagreement regarding the company’s operations, policies, or practices.

MicroVision, Inc. reported second quarter 2026 revenue of $1.47 million and a net loss of $36.94 million, or $1.66 per share, compared with revenue of $0.16 million and a net loss of $14.23 million a year earlier. Gross profit turned positive at $0.64 million, but operating expenses of $24.85 million led to a larger operating loss.

For the first half of 2026, revenue was $2.41 million and adjusted EBITDA was a loss of $36.03 million. Cash, cash equivalents and restricted cash totaled $28.87 million as of June 30, 2026, and the company states it has access to $68.4 million of capital, including $41.2 million under an at-the-market facility. Management highlighted a long-term development agreement with a leading construction and mining OEM to integrate its IRIS lidar into autonomous hauling vehicles and ongoing evaluations with customers in AI, e‑commerce logistics, defense and robotics as part of its Lidar 2.0 strategy.

MicroVision, Inc. is implementing a 1-for-15 reverse stock split of its common stock, approved by shareholders on July 10, 2026 and confirmed by a Certificate of Amendment filed in Delaware on July 22, 2026. The split becomes effective at 5:00 p.m. Eastern Time on August 1, 2026.

At effectiveness, every fifteen issued and outstanding common shares will be combined into one share, with fractional positions rounded up to the nearest whole share. Authorized capital stock will total 175,000,000 shares, including 150,000,000 common and 25,000,000 preferred; authorized common shares will be reduced from 510 million to 150 million. Outstanding options, warrants, convertible notes and equity plan reserves, and their exercise or conversion prices, will be adjusted proportionately. The stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market under “MVIS” on August 3, 2026, and the reverse split is intended to help satisfy Nasdaq’s minimum bid price requirement.

MicroVision, Inc. held its annual shareholder meeting on July 10, 2026, with shareholders present in person or by proxy representing 214,190,090 shares, or 62% of common stock entitled to vote. All seven director nominees were elected, each receiving more votes "For" than "Withheld".

Shareholders approved the issuance of common shares related to senior secured convertible notes issued on February 23, 2026, for purposes of complying with Nasdaq rules. They also approved amendments to the certificate of incorporation authorizing the Board to implement a reverse stock split at a ratio between 1-for-5 and 1-for-15 and to reduce authorized shares to 150 million within one year of the meeting.

On an advisory basis, shareholders approved executive compensation and ratified Baker Tilly US, LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.

MicroVision, Inc. furnished an update for investors by posting a CEO letter and detailed Q&A on its investor relations website. The materials address topics raised during the company’s June 25 virtual Business Update and Shareholder Q&A event and are attached as Exhibit 99.1.

The company states this information is provided under Regulation FD, is considered summary in nature, and should be read together with its other SEC filings and public announcements. The disclosure is furnished, not filed, and is not incorporated by reference into Securities Act registration statements.

MicroVision, Inc. filed a current report to alert investors that it has posted presentation slides from its June 25, 2026 virtual Business Update and Shareholder Q&A event on the investor relations section of its website. These slides are also attached as Exhibit 99.1.

The company states it may reuse or modify these slides in presentations to investors, analysts, and others throughout 2026. The information is being furnished under Regulation FD, not filed, meaning it is not subject to certain liability provisions and is not automatically incorporated into Securities Act registration statements.

MicroVision, Inc. filed an 8-K describing several capital markets and listing actions. The company amended its At-The-Market Issuance Sales Agreement with Deutsche Bank, Mizuho, and Craig-Hallum so it can continue selling common stock under a new Form S-3 registration statement. As of June 12, 2026, approximately $42 million of common stock remained available but unsold under this ATM facility.

MicroVision has applied to transfer its listing from The Nasdaq Global Market to The Nasdaq Capital Market to seek an additional 180-day period to regain compliance with Nasdaq’s $1.00 minimum bid price requirement. To regain compliance during that period, the stock must close at or above $1.00 for at least 10 consecutive business days, and there is no assurance the transfer or any additional grace period will be granted.

The company also highlighted an existing proposal for shareholders to approve a potential reverse stock split and announced a business update and interactive shareholder Q&A session scheduled for June 25, 2026 to discuss commercial progress, strategy, and matters related to the 2026 Annual Meeting.

MicroVision, Inc. filed a current report describing a new strategic collaboration in autonomous industrial equipment. The company has signed a long-term Master Development Agreement, with an initial Program Description dated June 1, 2026, to work with the world’s leading manufacturer of construction and mining equipment.

The partners aim to integrate MicroVision’s lidar and perception technologies into next-generation autonomous hauling solutions, initially using two Iris lidar sensors on each off-highway truck, with potential future use of the Halo sensor. MicroVision views the agreement as validating commercial momentum from its first-quarter asset acquisition and its available sensor inventory, while development, testing, and validation efforts are already underway to support the customer’s future autonomous product roadmap.

MicroVision, Inc. plans to seek shareholder approval to amend its certificate of incorporation to give its Board authority to implement a reverse stock split of its common stock at a ratio between 1-for-5 and 1-for-15, with the exact ratio set later by the Board.

The company has filed a preliminary proxy statement for its 2026 virtual Annual Meeting of Shareholders, scheduled for July 10, 2026 at 9:00 a.m. PT, where this proposal will be voted on. The Board set May 28, 2026 as the record date for shareholders entitled to vote.

Management states the reverse split is intended to support long-term shareholder value by helping preserve MicroVision’s Nasdaq listing, supporting capital flexibility, and targeting a stock price that may appeal to more stable, value-focused capital providers.

MicroVision, Inc. reported first quarter 2026 revenue of $935,000, up from $589,000 a year earlier, yielding gross profit of $363,000. Operating expenses rose sharply, leading to a loss from operations of $23.5 million.

Net loss was $25.3 million, or $0.08 per share, compared with a net loss of $28.8 million, or $0.12 per share, in the prior-year quarter. Adjusted EBITDA, a non-GAAP measure, was a loss of $17.2 million versus a loss of $10.7 million last year.

Cash and cash equivalents were $46.1 million as of March 31, 2026, up from $32.4 million at December 31, 2025, helped by $42.5 million of investment security sales and $20.7 million in net note proceeds. Net cash used in operating activities was $16.4 million. Management highlighted integration of Q1 2026 asset acquisitions from Luminar and Scantinel and a broadened lidar product portfolio.

MicroVision, Inc. filed an amended report to provide full financial details for its acquisition of Luminar Technologies’ LiDAR sensor business. MicroVision completed the asset purchase on February 3, 2026 under a January 26, 2026 agreement and paid total cash consideration of $33.2 million, including cure costs.

The filing adds audited carved‑out financials for the Luminar LiDAR Business and unaudited pro forma results. The acquired business generated $40.976 million of revenue in 2025 but reported a net loss of $280.7 million, following a $396.0 million loss in 2024. Its 2025 results include a $42.8 million loss on firm purchase commitments and $21.7 million of restructuring and other costs.

The auditor’s report highlights substantial doubt about the Luminar LiDAR Business’s ability to continue as a going concern due to the Parent’s recurring losses and Chapter 11 bankruptcy. As of December 31, 2025, $78.4 million of pre‑petition obligations were classified as liabilities subject to compromise, and reorganization items of $3.5 million were recorded in 2025.

MicroVision, Inc. furnished a new investor presentation under Regulation FD. The presentation, dated April 2026, is available on the company’s investor relations website and is attached as Exhibit 99.1. MicroVision expects to use this deck, in whole or in part, in presentations to investors, analysts and others throughout 2026.

The company states that the information in the presentation is summary in nature and should be read together with its SEC filings and other public announcements. The material is being furnished, not filed, so it is not subject to certain Exchange Act liabilities and will not be automatically incorporated into Securities Act registration statements.

MicroVision, Inc. reported that all of its executive officers and U.S.-based board members have committed to purchase shares of the company’s common stock directly from the company. Pursuant to subscription agreements signed March 15, 2026, they will buy an aggregate of $310,000 of stock at $0.5322 per share, matching Friday’s Nasdaq closing price.

Because of regulatory considerations, these insider purchases are structured as direct issuances by MicroVision rather than open‑market buys, so the full proceeds go to the company. The purchased shares will be restricted, and the participating directors and executives will hold them until they cease to be affiliates, aligning their financial exposure with the company’s long‑term performance.

MicroVision, Inc. reported fourth quarter and full year 2025 results showing a small revenue base and sizable losses as it transitions from R&D to commercial operations. Revenue was $223,000 for Q4 2025 and $1.2 million for the year, while net loss reached $37.8 million in Q4 and $95.0 million for 2025.

The company recorded significant non-cash charges, including a Q4 impairment loss on intangible assets of $10.1 million, plus impairments on lease right-of-use assets and property and equipment. Operating cash outflow for 2025 was $58.7 million, and cash, cash equivalents and restricted cash declined to $34.1 million as of December 31, 2025.

Management highlighted a strategic shift in early 2026, completing acquisitions of Luminar and Scantinel and beginning shipments on repeatable orders. To strengthen liquidity, MicroVision issued senior secured convertible notes with aggregate principal of $43.0 million, partly exchanging an existing note due March 2026, and retained access to an additional $43.0 million under an at-the-market equity facility.

MicroVision, Inc. filed a current report to share that it has issued a press release about a video-enabled business update and fireside chat scheduled for February 25, 2026 at 10:00 AM ET with Chief Executive Officer Glen DeVos.

The company notes it has completed two strategic acquisitions in the first two months of 2026, and the event will explore the business rationale for these deals, its near- and long-term roadmap, and its broader strategic vision for the lidar industry.

The interactive webcast, hosted by Hans-Werner Kaas of McKinsey & Company, will be accessible via MicroVision’s investor relations website and archived for future viewing, with investors able to submit questions in advance and during the live event.

MicroVision, Inc. entered into a financing deal with an institutional investor, issuing senior secured convertible notes with an aggregate principal amount of $43.0 million that mature on March 1, 2028. The notes are zero-coupon, senior to other debt, and secured by first-priority liens on the company’s and subsidiaries’ bank and securities accounts.

The structure combines an exchange of an existing 2026 secured convertible note into an approximately $20.6 million note due 2028 and the purchase of a new approximately $22.4 million note due 2028. The notes are redeemable in cash or, subject to conditions, in common stock at an initial conversion price of $0.8819 per share, with a cap of 61,315,970 shares until required Nasdaq stockholder approval is obtained.

Conversions are limited by a Beneficial Ownership Limitation initially set at 4.99%, adjustable up to 9.99%. The agreement includes covenants such as a minimum liquidity requirement of the greater of $21.5 million and 110% of aggregate principal, plus a defined cash burn test. MicroVision must file a resale registration statement for the underlying shares and seek shareholder approval by June 30, 2026. WestPark Capital will receive a $426,500 cash fee for placement services.

MicroVision, Inc. completed its previously announced acquisition of certain assets related to Luminar Technologies, Inc.’s lidar sensor business. On February 3, 2026, MicroVision closed the transaction and paid Luminar $33,000,000 in cash, funded entirely from MicroVision’s cash on hand.

The company plans to provide any required financial statements and pro forma financial information for the acquired assets in a later amendment, to be filed no later than 71 calendar days after this report was required to be filed.

MicroVision, Inc. entered into an Asset Purchase Agreement to acquire certain lidar sensor business assets from Luminar Technologies, Inc., including intellectual property and inventory related to Luminar’s Iris and Halo sensors. The acquisition excludes Luminar’s photonics business historically conducted by Luminar Semiconductor, Inc.

MicroVision agreed to pay a purchase price of $33,000,000, subject to potential adjustment under the agreement, and expects to fund the acquisition with current cash on hand. MicroVision was selected as the winning bidder in a competitive auction conducted under Section 363 of the U.S. Bankruptcy Code, and the U.S. Bankruptcy Court approved the agreement and related transactions on January 27, 2026. The obligations of both parties remain subject to customary closing conditions.

MicroVision, Inc. reported that it received a deficiency notice from Nasdaq on January 12, 2026 because its common stock failed to meet the minimum bid price requirement of $1 per share for the last 30 consecutive business days under Nasdaq Listing Rule 5450(a)(1). The notice does not immediately affect the listing or trading of its shares, and the company remains in compliance with all other Nasdaq continued listing standards. MicroVision has 180 days from the notice date to regain compliance and is evaluating available options, while its business operations, SEC reporting, and contractual obligations continue unchanged.

MicroVision, Inc. announced that Chief Financial Officer Anubhav Verma resigned from his position, effective no later than December 31, 2025. The company stated that his resignation did not result from any disagreement regarding financial statements, internal controls, operations, policies, or practices.

To support continuity, the Board appointed Stephen Hrynewich, currently Vice President, Global Finance & Operations, to serve as Interim Chief Financial Officer as of the effective date. Hrynewich was also designated as the company’s principal financial officer and principal accounting officer. MicroVision has begun a search to identify a permanent Chief Financial Officer.

MicroVision, Inc. filed a current report to inform investors that it has released its third quarter 2025 financial results. On November 11, 2025, the company issued a press release detailing these results, which is attached to the report as Exhibit 99.1 and incorporated by reference. The company notes that the information is being furnished rather than filed under securities laws, which affects how it is treated for legal liability purposes but still makes the earnings information available to the market.

MicroVision, Inc. is making a planned leadership change, promoting current Chief Technology Officer Glen W. DeVos to President and Chief Executive Officer and to the Board, effective September 30, 2025. Current CEO Sumit Sharma will serve until that date, after which his removal qualifies as an involuntary termination under the company’s Executive Severance and Change in Control Plan, entitling him to severance upon signing a customary release.

Under a new employment agreement, Mr. DeVos will receive a $530,000 annual base salary, a short-term incentive opportunity equal to 100% of base salary, and a grant of 539,000 RSUs that vest on June 6, 2026 only if specified company and individual objectives are met. The Board plans to set a longer-term equity structure for him in 2026. The Board also named director Simon Biddiscombe as Executive Vice Chair for up to 12 months, with a $265,000 salary and 241,000 RSUs vesting October 1, 2026. During this period he will not be an independent director, and Robert Carlile will become Audit Committee Chair.